Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Analysis/Commentary Strong EPS and Sales Growth Y-on-Y Beaten down at the start of the quarter, as health stocks generally are punished
Based on the study of the previous quarterly earnings reports and subsequent price moves: - Current quarter has given price move to the down side - Buy at oversold position on RSI (now) - Expectation for the price to move to TARGET RANGE during the financial quarter - Trailing stop-loss on price above TARGET PRICE
GOOD LUCK. DO YOUR OWN RESEARCH!
Comment
⋅
TRADE UPDATE: Unsuccessful to date Riding to quarter end for potential break-even